128 related articles for article (PubMed ID: 5457417)
1. [Results of combined treatment of generalized Hodgkin's disease with several cytostatic agents and corticosteroids].
Nowak S; Krzyzanowska-Woźniakows ; Lewicka T
Wiad Lek; 1970 Aug; 23(15):1339-44. PubMed ID: 5457417
[No Abstract] [Full Text] [Related]
2. Combination therapy with cyclophosphamide, vincristine, procarbazine and prednisone in Hodgkin's disease and reticulum cell sarcoma.
Isola LM; Cremerius de Sica SM; Palau M; Pereyra MA; Alzugaray AE
Medicina (B Aires); 1971; 31(2):93-7. PubMed ID: 4935790
[No Abstract] [Full Text] [Related]
3. [Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma].
Con I; Daiber A; Donoso A; Osorio G; Mora F
Rev Med Chil; 1972 Apr; 100(4):408-13. PubMed ID: 4557485
[No Abstract] [Full Text] [Related]
4. [Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
Goudemand M; Sautière-Habay D; Bauters F; Lerche-Habart B
Lille Med; 1968 Dec; 13(10):1102-7. PubMed ID: 4886051
[No Abstract] [Full Text] [Related]
5. Combination chemotherapy of advanced Hodgkin's disease.
Gray JL; Robinson WA
Rocky Mt Med J; 1973 Oct; 70(10):33-7. PubMed ID: 4748111
[No Abstract] [Full Text] [Related]
6. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
7. Approaches to improving the chemotherapy of Hodgkin's disease.
Frei E; DeVita VT; Moxley JH; Carbone PP
Cancer Res; 1966 Jun; 26(6):1284-9. PubMed ID: 5947352
[No Abstract] [Full Text] [Related]
8. Combination chemotherapy of advanced lymphomas.
Kurnick JE; Robinson WA
Arch Intern Med; 1972 Jun; 129(6):908-13. PubMed ID: 5067727
[No Abstract] [Full Text] [Related]
9. [Functional state of the liver in lymphogranulomatosis during drug and radiation treatment].
Danova LA; Filov VA
Vopr Onkol; 1972; 18(10):43-7. PubMed ID: 4662532
[No Abstract] [Full Text] [Related]
10. Hodgkin's disease of the spleen: some clinical aspects and problems.
Storti E; Casirola G; Marini G; Ippoliti G; Ascari E; Ferrari E
Haematologia (Budap); 1974; 8(1-4):493-505. PubMed ID: 4461434
[No Abstract] [Full Text] [Related]
11. Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risks.
Klumb CE; Carriço MK; de Rezende LM; Byington R; Bordallo MA; Bigni RS; Apa AG; Dobbin JA
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):628-9. PubMed ID: 17662581
[No Abstract] [Full Text] [Related]
12. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Cajozzo A; Citarrella P; Carreca I; D'Eredità F
Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
[No Abstract] [Full Text] [Related]
13. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
14. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
15. Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
Josting A; Nogová L; Franklin J; Glossmann JP; Eich HT; Sieber M; Schober T; Boettcher HD; Schulz U; Müller RP; Diehl V; Engert A
J Clin Oncol; 2005 Mar; 23(7):1522-9. PubMed ID: 15632410
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
[TBL] [Abstract][Full Text] [Related]
17. [Polychemotherapy of Hodgkin's disease].
Delage JM; Blouin R; Barry A
Union Med Can; 1970 Jun; 99(6):1062-7. PubMed ID: 5511498
[No Abstract] [Full Text] [Related]
18. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase II Study.
Miller TP; Jones SE; Rainey JM
Cancer Treat Rep; 1983; 67(7-8):739-40. PubMed ID: 6688200
[No Abstract] [Full Text] [Related]
19. [Combined treatment with corticosteroids and cyclophosphamide in the nephrotic syndrome in children].
Chaimowitz S; Surasky M; Levi J; Benderly A
Harefuah; 1972 Sep; 83(6):234-6. PubMed ID: 4650395
[No Abstract] [Full Text] [Related]
20. Greater curability in advanced Hodgkin's disease?
Portlock CS
Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
